Priority Date: 06.08.12 (US 201261680111P)

DUAL ANTI-PLATELET MEDICATION/ASPIRIN RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN

  • Application ID: EP13828269
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Mewburn Ellis LLP is specialized in C12. Mewburn Ellis LLP is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.08.2012 - Priority Date (US 201261680111P)
  • 13.02.2014 - Publication A2 (WO2014025685)
  • 10.06.2015 - Publication A2 (EP2880176)

IPC Classification